Up to now, it was revealed that CA-4 shuts down the tumor vascular, and inhibits the tumor growth and metastasis through targeting the colchicine-binding site of tubulin in a wide variety of preclinical tumor models1, 10. Here, CA4 is linked to neoplasm.